Skip to main navigation
Skip to search
Skip to main content
PubliRES - Publications, Research, Expertise and Skills Home
Italiano
English
Search content at PubliRES - Publications, Research, Expertise and Skills
Home
Profiles
Research units
Research output
Datasets
Natural killer cells in the treatment of high-risk acute leukaemia
Franco Locatelli
, Francesca Moretta
, Letizia Brescia
, Pietro Merli
Department of Health Science and Public Health
Faculty of Medicine and Surgery
IRCCS Ospedale pediatrico Bambino Gesù - Roma
Research output
:
Contribution to journal
›
Article
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Natural killer cells in the treatment of high-risk acute leukaemia'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Acute Leukemia
100%
Natural Killer Cell
100%
Therapeutic Procedure
100%
Donor
100%
Receptor
42%
Inpatient
42%
Antigen Presenting Cell
28%
Allogeneic Hematopoietic Stem Cell Transplantation
28%
Clinical Study
14%
Biological Product
14%
Transplantation
14%
Hematologic Malignancy
14%
Neoplasm
14%
Infusion
14%
Cancer Cell
14%
Therapy Effect
14%
Solid Malignant Neoplasm
14%
Ex Vivo
14%
Cell Therapy
14%
Innate Immunity
14%
Ligand
14%
Haplotype
14%
Allograft
14%
Cytomegalovirus Infection
14%
Adaptive Immunity
14%
Graft Rejection
14%
Graft Versus Host Reaction
14%
Patient
14%
Cells
14%
Volunteer
14%
Clinical Trial
14%
Cytotoxic T-Cell
14%
Immunology and Microbiology
Natural Killer Cell
100%
Allogeneic Hematopoietic Stem Cell Transplantation
28%
Biological Product
14%
Innate Immune System
14%
Cytotoxic T Cell
14%
Haplotype
14%
Transplantation
14%
Cytomegalovirus Infection
14%
Cancer Cell
14%
Adaptive Immune System
14%
Allotransplantation
14%
Transplant Rejection
14%
Graft-Versus-Host Disease
14%
Solid
14%
Cells
14%